The 2023 APCaRI Fall Symposium, held September 22nd and 23rd, was a huge success! Thank you all for joining us in beautiful Banff, Alberta.  The keynote and APCaRI member speakers gave inspiring and informative talks. We are especially appreciative of the participants representing patient advocacy groups, urologists, oncologists, funders, clinicians, trainees, and researchers who engaged in lively and productive conversation! Thank you again to our sponsors Astellas, AstraZeneca, Bayer, Janssen, Merck, and Pfizer who made this symposium possible. APCaRI looks forward to seeing all of you ..read more

In 1980, Terry ran for us. Now, it’s our turn to make a difference. Please help fund critical cancer research in Canada by supporting our team‘s participation in the 2023 Terry Fox Run. APCaRRRI will hit the pavement on Sunday, September 17th! The post 2023 Terry Fox Run appeared first on APCaRI ..read more

The APCaRI Fall Symposium 2022, held November 18-19, was a huge success! We thank our keynote speakers Dr. Chris Wallis, Dr. Paul Boutros, and Mr. Vijay Pandurangan for joining us in beautiful Banff, Alberta.  The keynote and APCaRI member speakers gave inspiring and informative talks. We are especially appreciative of the participants representing patient advocacy groups, urologists, oncologists, funders, clinicians, trainees, and researchers who engaged in lively and productive conversation! This year APCaRI also celebrated the many years of service from outgoing APCaRI Co-chairs Drs Jo ..read more

We’re meeting in person at the Banff Park Lodge (location and directions). This year the symposium features three invited speakers: Agenda_APCaRI Fall Symposium 2022 Dr. Chris Wallis, MD, PhD Assistant Professor, University of Toronto and Urologic Oncologist, Mount Sinai Hospital and University Health Network KEYNOTE on FRIDAY, NOV 18, 3-3:50 pm: “But what if….? Treatment regret in localized prostate cancer” Christopher Wallis obtained his Doctor of Medicine from the University of British Columbia and his Doctor of Philosophy in Clinical Epidemiology & Health Care Research from the Institu ..read more

October 12, 2022 – Edmonton, AB – Two powerhouse researchers in prostate cancer will change the way we treat the disease, thanks to funding from legendary volunteer fundraisers, the Bird Dogs and the Alberta Cancer Foundation. Working with the Alberta Cancer Foundation and the University of Alberta, the Bird Dogs have enabled a new one-term, five-year chair position to further prostate cancer research — the Bird Dogs Chair in Translational Oncology, a position to be held by researcher Dr. John Lewis. For the last 10 years, Dr. Lewis has held the Frank and Carla Sojonky Chair in Prostate ..read more

March 11, 2022 Congratulations to authors and APCaRI members Sunil Rajput, PhD, Desmond Pink, Scott Findlay, Emma Woolner, John Lewis, and Mark McDermott on their recent publication in ACS Sensors! The authors demonstrate a novel assay that detects and quantifies a specific protein biomarker in serum from advanced prostate cancer patients, leading to better-informed prostate cancer treatment. Article The post Application of Surface-Enhanced Raman Spectroscopy to Guide Therapy for Advanced Prostate Cancer Patients appeared first on APCARI ..read more

Original Story Published in Folio Magazine February 03, 2022 By Adrianna MacPherson Risk calculator helps pinpoint which patients are suitable for MRI-guided prostate biopsies that improve on the current standard of care. Adam Kinnaird, a surgeon and assistant professor in the Faculty of Medicine & Dentistry, and a member of both APCaRI and CRINA collaborated with colleagues at UCLA to develop a new risk calculator that could reduce the number of unnecessary and invasive biopsies for prostate cancer. Dr. Kinnaird explains that the tool is available online for free, requires only conve ..read more

Image of DREAM challenge winners, Russ Greiner pictured on far left. Dr. Russ Greiner, Canada CIFAR AI Chair, Fellow-in-Residence at Amii, University of Alberta Professor, and APCaRI member, received the CAIAC Lifetime Achievement Award announced at the Canadian AI Conference on May 27, 2021. This the highest honour bestowed by CAIAC, given in recognition to researchers who have distinguished themselves through outstanding research excellence in AI during the course of their academic career. APCaRI congratulates Russ Greiner for his well-deserved CAIAC Lifetime Achievement Award! “Using machin ..read more

The 1000th participant was recruited to the ClarityDX Prostate clinical validation study conducted at the DynaLIFE Accelerator Lab! We are getting closer to completing our training cohort for this study thanks to the APCaRI team. Way to go! We send a huge thank you to the patient participants who make this happen. The post Participation Milestone! appeared first on APCARI ..read more

Raja Singh APCaRI welcomes our new Director, Raja B. Singh who brings a wealth of precision health networking expertise to APCaRI. With over 12 years of experience in innovation, commercialization, and translational research, Raja has helped Canadian collaborative researchers and clinicians translate novel research from bench to market. We are excited to have Raja on board!   Catalina Vasquez APCaRI also sends thanks to outgoing Interim Director Catalina Vasquez for her dedication and service to APCaRI. Catalina worked tirelessly with APCaRI researchers, clinicians, funders, and patients ..read more